...
首页> 外文期刊>Cancer Science >Oncogenic Ras-mediated downregulation of Clast1/LR8 is involved in Ras-mediated neoplastic transformation and tumorigenesis in NIH3T3 cells
【24h】

Oncogenic Ras-mediated downregulation of Clast1/LR8 is involved in Ras-mediated neoplastic transformation and tumorigenesis in NIH3T3 cells

机译:Ras介导的Clast1 / LR8致癌基因下调与NIH3T3细胞的Ras介导的肿瘤转化和肿瘤发生有关

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Oncogenic Ras proteins transform cells by way of multiple downstream signaling pathways that promote the genesis of human cancers. However, the exact cellular mechanisms by which downstream targets are regulated are not fully understood. Here, we show that oncogenic Ras reduced Clast1/LR8 transcript levels in mouse NIH3T3 fibroblasts and human WI38 fibroblasts. Clast1/LR8 transcript was undetectable in H460, A549, and H1299 cells showing high Ras activity, but was relatively abundant in DMS53 cells displaying low Ras activity. We also showed that K-Ras siRNA restored Clast1/LR8 expression in H460 and A549 cells, and that inhibitors of DNA methylation and histone deacetylation reversed oncogenic H-Ras-mediated suppression of Clast1/LR8 transcription. Additionally, ectopic expression of Clast1/LR8 inhibited serum-stimulated phosphorylation of ERK1/2 and Akt in H-RasV12-transformed NIH3T3 cells. We further showed that the expression of Clast1/LR8 interfered with oncogenic Ras-induced NIH3T3 cell transformation and invasion. Finally, our results showed that Clast1/LR8 inhibited Ras-induced proliferation of, and tumor formation by, oncogenic H-RasV12-transformed NIH3T3 cells in vivo. This study identifies the downregulation of Clast1/LR8 as a potentially important mechanism by which oncogenic Ras-mediated neoplastic transformation occurs. (Cancer Sci 2010)
机译:致癌性Ras蛋白通过促进人类癌症发生的多个下游信号传导途径转化细胞。然而,尚未完全了解调控下游靶标的确切细胞机制。在这里,我们显示致癌性Ras降低了小鼠NIH3T3成纤维细胞和人WI38成纤维细胞中Clast1 / LR8转录水平。在具有高Ras活性的H460,A549和H1299细胞中无法检测到Clast1 / LR8转录本,但是在具有低Ras活性的DMS53细胞中相对丰富。我们还显示,K-Ras siRNA恢复了H460和A549细胞中Clast1 / LR8的表达,并且DNA甲基化和组蛋白去乙酰化的抑制剂逆转了致癌性H-Ras介导的Clast1 / LR8转录的抑制。此外,Clast1 / LR8的异位表达抑制了H-RasV12转化的NIH3T3细胞中血清刺激的ERK1 / 2和Akt磷酸化。我们进一步表明Clast1 / LR8的表达干扰致癌Ras诱导的NIH3T3细胞转化和侵袭。最后,我们的结果表明Clast1 / LR8在体内抑制了Ras诱导的致癌H-RasV12转化的NIH3T3细胞的增殖以及肿瘤的形成。这项研究确定Clast1 / LR8的下调是潜在的重要机制,通过该机制可能发生致癌的Ras介导的肿瘤转化。 (《癌症科学》 2010年)

著录项

  • 来源
    《Cancer Science》 |2010年第9期|p.1990-1996|共7页
  • 作者单位

    Department of Pharmacology, DNA Repair Research Center, Chosun University School of Medicine, Gwangju;

    |Department of Internal Medicine (Oncology), College of Medicine, Seoul National University, Seoul;

    |Department of Pharmacology, DNA Repair Research Center, Chosun University School of Medicine, Gwangju;

    Department of Pharmacology, DNA Repair Research Center, Chosun University School of Medicine, Gwangju;

    Department of Pharmacology, DNA Repair Research Center, Chosun University School of Medicine, Gwangju;

    Department of Pharmacology, DNA Repair Research Center, Chosun University School of Medicine, Gwangju;

    Department of Biochemistry, College of Medicine, Cheju National University, Jeju;

    Department of Thoracic and Cardiovascular Surgery, Gwangju;

    Department of Physiology, Chosun University School of Medicine, Gwangju, Korea;

    Department of Pharmacology, DNA Repair Research Center, Chosun Univ;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号